By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
RebruitRebruitRebruit
  • Latest
  • Finance
  • Technology
  • Security
  • Guides
Reading: 23andMe to Go Private: Wojcicki and New Mountain Capital Offer $74.7 Million
Font ResizerAa
RebruitRebruit
Font ResizerAa
Search
  • Latest
  • Finance
  • Technology
  • Security
  • Guides
Follow US
  • About
  • Our Standards
  • Contact
  • Privacy Policy
  • Cookie Policy
  • Terms of use
© 2025 REBRUIT | We don’t control content on external sites. Read more about how we handle external links

Home » 23andMe to Go Private: Wojcicki and New Mountain Capital Offer $74.7 Million

Latest

23andMe to Go Private: Wojcicki and New Mountain Capital Offer $74.7 Million

A New Chapter for 23andMe: Privatization Looms Amid Tumultuous Times.

February 23, 2025
Share
6 Min Read
23andme
SHARE

23andMe, the once-high-flying genetic testing company, is at a crossroads. On February 21, 2025, CEO Anne Wojcicki and New Mountain Capital filed a proposal with the U.S. Securities and Exchange Commission (SEC) to take the struggling firm private, offering $2.53 per share in cash—a total equity value of approximately $74.7 million.

Contents
The Offer: A Premium Amid a StormA Year of Turmoil and TransitionWojcicki’s Vision Meets New Mountain’s MuscleWhat’s Next for 23andMe?

With the stock closing at $2.42 that day, reflecting a market cap of $65 million, this move marks the latest chapter in a turbulent year for the company. After losing over 80% of its value in 2024, 23andMe’s leadership is betting on privatization to stabilize its future. Here’s a closer look at the proposal, its context, and what it means for the genetic testing pioneer.

The Offer: A Premium Amid a Storm

Wojcicki, 23andMe’s co-founder, and New Mountain Capital, a New York-based firm managing $55 billion in assets, have teamed up to acquire all outstanding shares of the company. Their $2.53-per-share bid represents a modest 4.5% premium over Friday’s closing price, aiming to deliver “compelling value and immediate liquidity” to shareholders, as stated in a letter to the company’s special committee. This follows a challenging 2024, during which the stock plummeted from its January highs, prompting the company to explore strategic options—ranging from a full sale to restructuring or a business combination.

The proposal arrives after a rejected July offer from Wojcicki alone, which priced shares at just 40 cents—a figure the special committee dismissed for lacking committed financing and failing to offer a premium. This time, with New Mountain’s backing and a promise of secured debt financing to sustain operations through the deal’s closure, the duo aims to address those concerns head-on.

SEO Keywords: 23andMe privatization 2025, Anne Wojcicki proposal, New Mountain Capital deal, genetic testing stock

A Year of Turmoil and Transition

23andMe’s 2024 was marked by volatility. The company, which went public in 2021 via a SPAC merger, valuing it at $3.5 billion, has struggled to maintain momentum. Its core business of at-home DNA testing kits—once a consumer sensation—has faced declining sales, while efforts to pivot into drug development using its genetic database have yet to yield significant revenue. By January 2025, with shares trading well below their IPO price, 23andMe signaled a strategic review to chart an alternative course.

The boardroom has seen its own upheaval. In September 2024, all seven independent directors resigned abruptly, reportedly frustrated with Wojcicki’s earlier privatization efforts. Three new independent directors joined in October, forming a special committee tasked with evaluating the company’s next steps. This committee now holds the key to approving or rejecting the latest proposal, a decision that could redefine 23andMe’s trajectory.

SEO Keywords: 23andMe stock decline, board resignations 2024, strategic alternatives, genetic testing industry

Wojcicki’s Vision Meets New Mountain’s Muscle

Wojcicki, who retains significant voting power as a co-founder, has long signaled her intent to steer 23andMe away from public market pressures. Her latest effort, bolstered by New Mountain Capital’s financial clout, reflects a belief that privatization could unlock the company’s potential—free from quarterly scrutiny—to focus on its mission of integrating genetics into healthcare. “We believe this proposal offers a clear path forward for shareholders,” Wojcicki and Matthew Holt, New Mountain’s private equity president, wrote in their Thursday letter to the committee.

New Mountain’s involvement adds credibility. With $55 billion in assets under management, the firm brings the resources to stabilize 23andMe’s finances, including a commitment to fund operations through the transaction via secured debt. This contrasts sharply with the financing gaps that sank Wojcicki’s prior bid, signaling a more robust plan to execute the privatization.

SEO Keywords: Anne Wojcicki 23andMe, New Mountain Capital investment, secured debt financing, privatization strategy

What’s Next for 23andMe?

The special committee’s decision looms large. Charged with safeguarding shareholder interests, it must weigh the $74.7 million offer against other potential paths—whether remaining public or pursuing an alternative deal. The 4.5% premium, while modest, provides immediate cash in a year when 23andMe’s valuation has cratered. Yet, critics may argue it undervalues the company’s vast genetic database, a potential goldmine for future biotech breakthroughs.

For now, 23andMe stands at a pivotal moment. Once a darling of the consumer genetics boom, it now seeks refuge in private hands to rebuild. Will Wojcicki and New Mountain’s vision prevail, or will the committee chart a different course? The answer will shape the future of a company that, despite its struggles, remains a key player in the genetics space. Share your thoughts on 23andMe’s next move in the comments below.

Share This Article
Facebook Whatsapp Whatsapp Bluesky Copy Link
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

iOS 19
What’s Coming in iOS 19: A Fresh Look and Smarter Features
Technology
Block
Square’s Bitcoin Payment Pilot: Bringing Crypto to Everyday Retail
Finance
METAMASK
MetaMask Embraces Solana: A New Era for Multi-Chain Wallets
Finance
Read Smarter, Not Harder
Read Smarter, Not Harder: These Apps Will Help You Read More Anywhere
Guides
Samsung-One-UI-8
15+ New Features Coming to One UI 8
Latest

You Might Also Like

samsung
Latest

Don Belle Boost Samsung Galaxy A-Series Buzz

May 23, 2025
Claude AI
Latest

What You Need to Know About the Claude 4 Release

May 23, 2025
Xperia 1 VII
Latest

Xperia 1 VII: Sony’s Most Creator-Focused Smartphone Yet

May 13, 2025
Apple’s AI Search Move Could Cost Google Billions
Latest

Apple’s AI Search Move Could Cost Google Billions

May 13, 2025
AMD Beats Q1 2025 Expectations, Despite Trade Pressures Between the U.S. and China
Latest

AMD Beats Q1 2025 Expectations, Despite Trade Pressures Between the U.S. and China

May 6, 2025
gtaVI
Latest

Grand Theft Auto VI is officially coming on May 26, 2026

May 6, 2025
WWDC 2025: Here’s what we can expect from Apple in June
Latest

WWDC 2025: Here’s what we can expect from Apple in June

May 5, 2025
Apple and Anthropic Are Teaming Up to Build an AI-Powered Coding Platform
Latest

Apple and Anthropic Are Teaming Up to Build an AI-Powered Coding Platform

May 3, 2025
Follow US
© 2025 REBRUIT | We don’t control content on external sites. Read more about how we handle external links
  • About
  • Our Standards
  • Contact
  • Privacy Policy
  • Cookie Policy
  • Terms of use
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?